EcoDrugPlus

Tyrosinase

Ensembl ID : ENSCPOG00000010608
Gene Symbol: TYR
2 Cross references
266 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSCPOG00000012591
Gene Symbol: TH
2 Cross references
188 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSCPOG00000004366
Gene Symbol: TYK2
2 Cross references
197 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSCPOG00000006080
Gene Symbol: TIE1
4 Cross references
205 Possible Orthologues:

Utrophin

Ensembl ID : ENSCPOG00000000837
Gene Symbol: UTRN
2 Cross references
268 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSCPOG00000013559
Gene Symbol: VEGFA
3 Cross references
254 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSCPOG00000036166
Gene Symbol: VDR
2 Cross references
466 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSCPOG00000006310
Gene Symbol: VKORC1
4 Cross references
190 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSCPOG00000005074
Gene Symbol: XDH
4 Cross references
210 Possible Orthologues:

Ensembl ID : ENSCPOG00000019542
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSCPOG00000040610
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSCPOG00000022615
Gene Symbol: -
Cross references: -
227 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).